Thermo Fisher Scientific Inc (TMO) : $50.55 million worth of transactions were on upticks in Thermo Fisher Scientific Inc (TMO), compared to $27.88 million on downticks. The ratio between the two was 1.81, whereas, the net money flow stood at a healthy $22.67 million on Wednesdays session. The consistent buying on upticks in the stock accounted for $22.3million worth of trades. The total money flow into the stock stood at $22.3 million. The bulls and the bears were in an equilibrium as the stock closed with a loss of -0.15%. The stock was trading at $158.64, with a drop of $0.24 over the previous days close. The stock recorded 0.62% for the week.
Shares of Thermo Fisher Scientific, Inc. rose by 2.07% in the last five trading days and 3.45% for the last 4 weeks. Thermo Fisher Scientific, Inc. is up 9.4% in the last 3-month period. Year-to-Date the stock performance stands at 12.18%.
Thermo Fisher Scientific Inc (TMO) has an average broker rating of 1.5, which is interpreted as a Strong Buy, as rated by 13 equity analysts. Nonetheless, 10 analysts are positive on the stocks future and they recommend a Strong Buy on the stock. 1 other analysts advise a Buy. Nevertheless, the majority of 1 analysts consider that the stock is a Hold with neither a large upside nor a downside. Ranking by Zacks Investment Research for Coach Inc is 3, which is also a Hold. 1 brokerage firm advices Strong Sell on the share due to lack of confidence about the future of the company.
Thermo Fisher Scientific Inc (NYSE:TMO): stock was range-bound between the intraday low of $157.14 and the intraday high of $159.09 after having opened at $159.09 on Wednesdays session. The stock finally closed in the red at $159.09, a loss of -0.15%. The stock remained in the red for the whole trading day. The total traded volume was 946,741 shares. The stock failed to cross $159.09 in Wednesdays trading. The stocks closing price on Thursday was $158.88.
Thermo Fisher Scientific Inc. is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, provides reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments, provides instruments, consumables, software and services that are used in the laboratory; Specialty Diagnostics, offers diagnostic test kits, reagents, culture media, instruments and associated products, and Laboratory Products and Services, offers self-manufactured and sourced products for the laboratory.